Aspirin Benefit Blunted in People With Diabetes

| Apr 1, 2004

An aspirin a day has long been a low-cost preventive therapy to reduce cardiovascular events.

But the Primary Prevention Project (PPP), a randomized trial of nearly 5,000 subjects in Italy-including 1,031 with diabetes-concluded that people with diabetes benefit less than other people with cardiovascular risk factors.

Among people with diabetes, low-dose aspirin (100 mg/day) treatment yielded an insignificant increase in cardiovascular deaths, but it also produced an insignificant reduction in the composite endpoint (total cardiovascular deaths, strokes or heart attacks) and total cardiovascular events.

The results for nondiabetics were more favorable.

The trial was stopped after three and a half years because a consistent benefit overall was found for aspirin therapy compared with the control group. Investigators theorize the anti-platelet effects of aspirin are overwhelmed by aspirin-insensitive mechanisms of platelet activation and thrombus formation common in diabetics.

The researchers note that further large-scale trials addressing the role of aspirin in the primary prevention of cardiovascular disease in people with diabetes are urgently needed.

The PPP study also investigated the role of vitamin E (300 mg/day) in preventing cardiovascular events in people with cardiovascular risk factors. No significant benefit was found with vitamin E in either diabetic or non-diabetic study participants.

-Diabetes Care, December 2003

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Heart Care & Heart Disease, Medications Research


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.